Search Raise Health

RAISE Health

Register Now

Tracing the role of AI across the pharmaceutical lifecycle, from biomedical innovation to patient experience, focusing on how new capabilities can deliver meaningful, real-world impact.

Register now to secure your spot. Additional speakers to be announced soon. 

1:10–1:15 PM | Opening Remarks

  • Lloyd Minor, Dean, Stanford University School of Medicine and Vice President for Medical Affairs, Stanford University

1:15–1:45 PM | Fireside Chat

How is AI reshaping the pharmaceutical pipeline today—and what has that experience revealed about what works, what doesn’t, and why?

  • Chris Boerner, Board Chair and CEO, Bristol Myers Squibb 
  • Moderator: Lloyd Minor, Dean, Stanford School of Medicine and Vice President for Medical Affairs, Stanford University

1:45–2:15 PM | Lightning Talks and AI Demos

Where AI Is Already Delivering Value In Translational Medicine?

2:15–2:45 PM | Accelerating Discovery in Cancer

What new possibilities are emerging as advances in AI infrastructure and foundational models are applied to cancer discovery and translation?

  • Kimberly Powell, VP of Healthcare, NVIDIA

  • Aviv Regev, Head of Genentech Research and Early Development, Genentech

2:45–3:00 PM | Break

3:00–3:30 PM | AI for Cancer Patient Journey

How can AI meaningfully improve the cancer patient journey while helping providers deliver timely and tailored care?

3:30–4:00 PM | Fireside Chat: Regulatory Perspective

What will it take for AI innovations to earn trust and scale safely across health care?

4:00 PM | Closing Remarks 

Registration Types

  • Academic: Faculty, researchers, clinicians, and staff affiliated with universities, academic medical centers, healthcare delivery organizations, nonprofits, and government or public sector agencies.

Academic Pricing: $100 / $200 (Early / Regular)

  • Industry: Professionals affiliated with commercial entities, including healthcare technology companies, life sciences and pharmaceutical firms, startups, consulting firms, and investor or venture capital groups.

Industry Pricing: $250 / $350 (Early / Regular)

  • Trainee: Full-time students and clinical/research trainees, including undergraduate, graduate, postdoctoral, medical, and residency or fellowship trainees.

Trainee Pricing: No cost

 

Notes

  • Early registration rates expire April 30, 2026

  • All registration fees are non-refundable. Registrations may be transferred to another individual if you are unable to attend.

  • Program details and schedules are subject to change.

Featured Speakers

Chris Boerner | Board Chair and CEO, Bristol Myers Squibb

Christopher Boerner is board chair and chief executive officer at Bristol Myers Squibb. Prior to assuming his current role, he served as executive vice president, chief operating officer and chief executive officer designate from April to November 2023. 

Kimberly Powell | VP of Healthcare, NVIDIA

Kimberly is responsible for the company’s worldwide healthcare business, including hardware and software platforms for accelerated computing, AI, and visualization that power the ecosystem of medical imaging, life sciences, drug discovery, and healthcare analytics. Kimberly received a BS in electrical engineering from Northeastern University in Massachusetts.

Aviv Regev | Head of Genentech Research and Early Development, Genentech

Aviv Regev is head of Genentech Research and Early Development. Formerly, Regev was Chair of the Faculty and Core Member at the Broad Institute of MIT and Harvard, Professor of Biology at MIT, and a Howard Hughes Medical Institute Investigator. She is founding co-chair of the Human Cell Atlas and a leader in deciphering molecular circuits that govern cells, tissues, and organs in health and their malfunction in disease.